Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice

Diabetologia

Volumn 55, Issue 6, 2012, Pages 1813-1823

  Xu, G ^a   Wang, Z ^c   Li, Y ^a   Li, Z ^a   Tang, H ^a   Zhao, J ^a   Xiang, X ^a   Ding, L ^a   Ma, L ^a   Yuan, F ^a   Fei, J ^b   Wang, W ^a   Wang, N ^a   Guan, Y ^a   Tang, C ^a   Mulholland, M ^d   Zhang, W ^a,d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Ghrelin; Glucose metabolism; Rapamycin

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 4; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; PROTEIN INHIBITOR; PROTEIN S6; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE; GHRP 6, LYS(3); GHRP-6, LYS(3)-; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; DOWN REGULATION; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; GENE; GENE DELETION; GENE INACTIVATION; GHSR1A GENE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC REGULATION; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR BLOCKING; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; DRUG ANTAGONISM; GENETICS; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; RADIOIMMUNOASSAY;

ANIMALS; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OLIGOPEPTIDES; RADIOIMMUNOASSAY; RECEPTORS, GHRELIN; RIBOSOMAL PROTEIN S6; SIROLIMUS;

EID: 84865424560     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2509-1     Document Type: Article

References (49)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660 (Pubitemid 129516334)
2. Cummings DE, Foster-Schubert KE, Overduin J (2005) Ghrelin and energy balance: focus on current controversies. Curr Drug Targets 6:153-169 (Pubitemid 40394311)
3. Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85:495-522 (Pubitemid 40404635)
4. Vestergaard ET, Gormsen LC, Jessen N et al (2008) Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 57:3205-3210
5. Dezaki K, Hosoda H, Kakei M et al (2004) Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 53:3142-3151 (Pubitemid 39564489)
6. Dezaki K, Sone H, Koizumi M et al (2006) Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 55:3486-3493 (Pubitemid 44923609)
7. Zigman JM, NakanoY CR et al (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115:3564-3572 (Pubitemid 43121844)
8. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S (2009) Expression of ghrelin and its receptor in human tissues. Horm Metab Res 41:814-821
9. An W, Li Y, Xu G et al (2010) Modulation of ghrelin O-acyltransferase expression in pancreatic islets. Cell Physiol Biochem 26:707-716
10. Abraham RT, Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14:483-510 (Pubitemid 26130192)
11. Polak P, Hall MN (2009) mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21:209-218
12. Kahn BB, Myers MG Jr (2006) mTOR tells the brain that the body is hungry. Nat Med 12:615-617 (Pubitemid 43869941)
13. Cota D, Proulx K, Smith KA et al (2006) Hypothalamic mTOR signaling regulates food intake. Science 312:927-930 (Pubitemid 43727328)
14. Houde VP, Brule S, Festuccia WT et al (2010) Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 59:1338-1348
15. Bell E, Cao X, Moibi JA et al (2003) Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52:2731-2739 (Pubitemid 37339702)
16. Fraenkel M, Ketzinel-Gilad M, Ariav Y et al (2008) mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945-957
17. Johnston O, Rose CL, Webster AC, Gill JS (2008) Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 19:1411-1418
18. Friedman EA, Shyh TP, Beyer MM, Manis T, Butt KM (1985) Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 5:196-202 (Pubitemid 15120354)
19. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178-185 (Pubitemid 36323115)
20. Rodrigo E, Fernandez-Fresnedo G, Valero R et al (2006) Newonset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 17:S291-S295 (Pubitemid 44865264)
21. Ma XM, Blenis J (2009) Molecular mechanisms of mTORmediated translational control. Nat Rev Mol Cell Biol 10:307-318
22. Khamzina L, Veilleux A, Bergeron S, Marette A (2005) Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats, possible involvement in obesitylinked insulin resistance. Endocrinology 146:1473-1481 (Pubitemid 40289337)
23. Harrington LS, Findlay GM, Gray A et al (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166:213-223 (Pubitemid 38988774)
24. Shah OJ, Wang Z, Hunter T (2004) Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14:1650-1656 (Pubitemid 39239362)
25. Um SH, Frigerio F, Watanabe M et al (2004) Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200-205 (Pubitemid 39243474)
26. Tremblay F, Brule S, Hee Um S et al (2007) Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance. Proc Natl Acad Sci U S A 104:14056-14061 (Pubitemid 350003334)
27. Le Bacquer O, Petroulakis E, Paglialunga S et al (2007) Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4EBP2. J Clin Invest 117:387-396 (Pubitemid 46203967)
28. Polak P, Cybulski N, Feige JN, Auwerx J, Ruegg MA, Hall MN (2008) Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 8:399-410
29. Xu G, Li Y, An W et al (2010) Regulation of gastric hormones by systemic rapamycin. Peptides 31:2185-2192
30. Xu G, Li Y, An W et al (2009) Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology 150:3637-3644
31. Wang W, Wang Z, Zhang Y, Fei J, Zheng Q (2008) Generation of mouse embryonic stem cell clones for ghrelin receptor gene knock out. Chin J Bases Clin General Surg 15:733-736
32. Marette A, Richardson JM, Ramlal T et al (1992) Abundance, localization, and insulin-induced translocation of glucose transporters in red and white muscle. Am J Physiol 263:C443-C452
33. James DE, Strube M, Mueckler M (1989) Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338:83-87 (Pubitemid 19076789)
34. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE (1991) Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A 88:7815-7819 (Pubitemid 21915245)
35. Dezaki K, Sone H, Yada T (2008) Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 118:239-249
36. Yang Q, Guan KL (2007) Expanding mTOR signaling. Cell Res 17:666-681 (Pubitemid 47255937)
37. Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13:252-259 (Pubitemid 46836871)
38. Tremblay F, Marette A (2001) Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276:38052-38060
39. Santos JM, Ribeiro SB, Gaya AR, Appell HJ, Duarte JA (2008) Skeletal muscle pathways of contraction-enhanced glucose uptake. Int J Sports Med 29:785-794
40. Wang Y, Nishi M, Doi A et al (2010) Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells. FEBS Lett 584:1503-1508
41. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J (2002) Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146:241-244 (Pubitemid 34162918)
42. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG (2006) Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3:379-386
43. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L (2004) Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A 101:2924-2929 (Pubitemid 38327712)
44. Perez-Tilve D, Hofmann SM, Basford J et al (2010) Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci 13:877-882
45. Filigheddu N, Gnocchi VF, Coscia M et al (2007) Ghrelin and desacyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 18:986-994 (Pubitemid 46399502)
46. Zhang W, Zhao L, Mulholland MW (2007) Ghrelin stimulates myocyte development. Cell Physiol Biochem 20:659-664 (Pubitemid 47340626)
47. Wang PY, Caspi L, Lam CK et al (2008) Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452:1012-1016 (Pubitemid 351589616)
48. Kokorovic A, Cheung GW, Breen DM, Chari M, Lam CK, Lam TK (2011) Duodenal mucosal protein kinase C-ä regulates glucose production in rats. Gastroenterology 141:1720-1727
49. Ross R, Wang PY, Chari M et al (2008) Hypothalamic protein kinase C regulates glucose production. Diabetes 57:2061-2065